Cervical Cancer Screening: Risk factors for cervical neoplasia among rural women of Nanded Maharashtra

Cite this:
[1]
D. S. T. Khamankar, D. V. Belekar, V. M. Bhagat, and D. S. R. Baviskar, “Cervical Cancer Screening: Risk factors for cervical neoplasia among rural women of Nanded Maharashtra”, ijmhs, vol. 4, no. 1, Jan. 2014.
© 2022 Interactive Protocols
RIGHTS & PERMISSIONS
Article Views
255
Altmetric
1
Citations
-
LEARN ABOUT THESE METRICS
   PDF  

Abstract

Cancer of the cervix uteri is the second most common cancer among women worldwide; most frequent cancer in women in India. It is also the most common cancer in women in many parts of the world including South-Central Asia. Papanicolaou (pap) smear detects aberrations (if any) in cervix epithelium i.e. dysplasia and early cervix cancer. It is the most appropriate method over HPV screening or HPV vaccination in Indian settings. Screening of high risks for cervical cancer with pap smear will yield better in terms of lives saved and cancers prevented. The present study was conducted to study cytological findings in cervical discharge by Pap smear and to evaluate role of cytology in early detection of cellular aberration like cervical squamous intraepithelial lesions and malignancy by The Bethesda System -2001. Age, premalignant cervical epithelial changes, post menopausal women and high parity were observed to be risk factors for cervical neoplasia on pap smear. Increasing parity is observed to be significantly and independently increases risk of cervical neoplasia. Screening of women in reproductive age by pap smear for cervical cancer is recommended especially in resource poor countries like India.

KEYWORDS:

 Special Issue

References

1. Ferlay J, Shin HR, Forman D, Mathers C and Parkin DM. Estimates of worldwide burden of cancer in 2008: GLOBOCAN 2008. Int. J. Cancer: 127, 2893–2917 (2010). 2. Kaarthigeyan K. Cervical cancer in India and HPV vaccination. Indian J Med Paediatr Oncol. 2012 Jan-Mar; 33(1): 7–12. 3. Nanakumar A. Ramnath T. Chaturvedi M. The magnitude of cancer cervix in India. Indian J Med Res 130, Sept.2009, 219-221. 4. Aswathy S., Mariya Amin Quereshi, Beteena Kurian & Leelamoni K. Cervical cancer screening: Current knowledge & practice among women in a rural population of Kerala, India. Indian J Med Res 136, Aug.2012,205-210. 5. Varghese C, Amma NS, Chitrathara K, Dhakad N, Rani P, Malathy L. et. al. Risk factors for cervical dysplasia in Kerala, India. Bulletin of the World Health Organization, 1999, 77 (3). 6. Chichareon S, Herrero R, Mun˜oz N, Bosch FX, Jacobs MV, Deacon J, Santamaria M, Chongsuvivatwong V, Meijer CJLM, Walboomers JMM. Risk Factors for Cervical Cancer in Thailand: a Case–Control Study. J Natl Cancer Inst 1998;90:50–7. 7. Saslow D, Carolyn D. Runowicz, Solomon D,Anna-Barbara Moscicki AB,Smith RA, Harmon J. Eyre HJ, Cohen C American Cancer Society Guideline for the Early Detection of Cervical Neoplasia and Cancer. CA Cancer J Clin 2002;52:342-362.

Article Metrics Graph

Chart Graph | Range Graph

Content

Section

References

1. Ferlay J, Shin HR, Forman D, Mathers C and Parkin DM. Estimates of worldwide burden of cancer in 2008: GLOBOCAN 2008. Int. J. Cancer: 127, 2893–2917 (2010).
2. Kaarthigeyan K. Cervical cancer in India and HPV vaccination. Indian J Med Paediatr Oncol. 2012 Jan-Mar; 33(1): 7–12.
3. Nanakumar A. Ramnath T. Chaturvedi M. The magnitude of cancer cervix in India. Indian J Med Res 130, Sept.2009, 219-221.
4. Aswathy S., Mariya Amin Quereshi, Beteena Kurian & Leelamoni K. Cervical cancer screening: Current knowledge & practice among women in a rural population of Kerala, India. Indian J Med Res 136, Aug.2012,205-210.
5. Varghese C, Amma NS, Chitrathara K, Dhakad N, Rani P, Malathy L. et. al. Risk factors for cervical dysplasia in Kerala, India. Bulletin of the World Health Organization, 1999, 77 (3).
6. Chichareon S, Herrero R, Mun˜oz N, Bosch FX, Jacobs MV, Deacon J, Santamaria M, Chongsuvivatwong V, Meijer CJLM, Walboomers JMM. Risk Factors for Cervical Cancer in Thailand: a Case–Control Study. J Natl Cancer Inst 1998;90:50–7.
7. Saslow D, Carolyn D. Runowicz, Solomon D,Anna-Barbara Moscicki AB,Smith RA, Harmon J. Eyre HJ, Cohen C American Cancer Society Guideline for the Early Detection of Cervical Neoplasia and Cancer. CA Cancer J Clin 2002;52:342-362.

Source

License

All paper submissions must carry the following duly signed by all the authors:
“I certify that I have participated sufficiently in the conception and design of this work and the analysis of the data (wherever applicable), as well as the writing of the manuscript, to take public responsibility for it. I believe the manuscript represents valid work. I have reviewed the final version of the manuscript and approve it for publication. Neither has the manuscript nor one with substantially similar content under my authorship been published nor is being considered for publication elsewhere, except as described in an attachment. Furthermore I attest that I shall produce the data upon which the manuscript is based for examination by the editors or their assignees, if requested.”